January 9, 2012 β Janssen Research and Development, LLC (JRD) announced today that it has submitted a supplemental new ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
January 09, 2012
January 6, 2012 β People with high cholesterol are at risk of heart attack and stroke because atherosclerotic plaques ...
January 06, 2012
January 5, 2011 β Bayer HealthCare's oral anticoagulant tablet Xarelto (rivaroxaban) has been approved for use in the ...
January 05, 2012
December 20, 2011 β The U.S. Food and Drug Administration (FDA) completed a safety review of the anti-arrhythmia drug ...
December 20, 2011
Β
December 5, 2011 β Roche announced that it has signed an agreement under which it will acquire 100 percent of Verum ...
December 05, 2011
December 5, 2011 β The U.S. Food and Drug Administration (FDA) approved the first generic version of the cholesterol ...
December 05, 2011
November 17, 2011 β Westside Medical Imaging of Beverly Hills announces the availability of high resolution magnetic ...
November 18, 2011
Β
November 18, 2011 β An analysis of the TRITON-TIMI 38 trial presented today in an oral session at the American Heart ...
November 18, 2011November 16, 2011 β Johnson & Johnson Pharmaceutical Research & Development announced that adding oral rivaroxaban to ...
November 16, 2011November 16, 2011 β Non-adherence to antiplatelet therapy β which prevents blood clots following percutaneous coronary ...
November 16, 2011
November 15, 2011 β A clinical trial of patients undergoing percutaneous coronary intervention (PCI) for acute coronary ...
November 15, 2011
November 15, 2011 β A clinical trial comparing prasugrel to clopidogrel for patients with high on-clopidogrel platelet ...
November 15, 2011
November 15, 2011 β Results of ADAPT-DES (Assessment of Dual AntiPlatelet Therapy with Drug-Eluting Stents) were ...
November 15, 2011
November 15, 2011 β Data from the BRIDGE clinical trial demonstrate that intravenous use of the drug cangrelor was ...
November 15, 2011
November 11, 2011 β The 30-day results from the 8,500+ patient ADAPT-DES registry were presented at the 2011 TCT ...
November 11, 2011